Search Results - "Caligo, M.A."

465: A possible genetic signature of DNA repair genes in triple negative breast cancers by a NGS approach by Spugnesi, L, Gabriele, M, Tancredi, M, Gaetana, G, Maresca, L, Salvadori, B, Bertolini, I, Caligo, M.A

Get full text

868 From Yeast Genetics to BRCA2 Tumorigenesis – Developing a New Functional Assay to Characterize Missense Variants by Spugnesi, L, Balia, C, Collavoli, A, Caligo, M.A, Quercioli, V, Galli, A

Get full text

607 Genes Deregulated in HeLa Cells Expressing BRCA1 Missense Variants Are Involved in DNA Double Strand Breaks Repair by Homologous Recombination by Guglielmi, C, Collavoli, A, Cerri, I, Aretini, P, Tancredi, M, Caligo, M.A

Get full text

Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: A retrospective study in a sample of Italian cancer genetics clinics by Varesco, L, Viassolo, V, Viel, A, Gismondi, V, Radice, P, Montagna, M, Alducci, E, Della Puppa, L, Oliani, C, Tommasi, S, Caligo, M.A, Vivanet, C, Zuradelli, M, Mandich, P, Tibiletti, M.G, Cavalli, P, Lucci Cordisco, E, Turchetti, D, Boggiani, D, Bracci, R, Bruzzi, P, Bonelli, L

“…Abstract Purpose To evaluate in current practice the performance of BOADICEA and BRCAPRO risk models and empirical criteria based on cancer family history for…”
Get full text

762 PALB2: a new inactivating mutation in a breast cancer family by Caligo, M.A, Balia, C, Guglielmi, C, Lombardi, G, Bevilacqua, G

Get full text

PROMs in post-mastectomy care: Patient self-reports (BREAST-Q™) as a powerful instrument to personalize medical services by Ghilli, M., Mariniello, M.D., Camilleri, V., Murante, A.M., Ferrè, F., Colizzi, L., Gennaro, M., Caligo, M.A., Scatena, C., Del Re, M., Nuti, S., Caramella, D., Roncella, M.

“…One of the goals of immediate breast reconstruction (IBR) is to satisfy the patient's outcome. Recent studies therefore tended to focus on the patient's…”
Get full text

515P - Clinical Presentation in Brca1/2 Mutation Carriers: A Single-Institution Experience by Fontana, A., Aretini, P., Ferrarini, I., Bona, E., Stasi, I., Landucci, E., Allegrini, G., Roncella, M., Caligo, M.A., Falcone, A.

“…Genetic testing for BRCA1/2 mutations may be useful for prevention and close surveillance as well for treatments selection in cancer patients. Between May 2001…”
Get full text

Clinical Presentation in Brca1/2 Mutation Carriers: A Single-Institution Experience by Fontana, A., Aretini, P., Ferrarini, I., Bona, E., Stasi, I., Landucci, E., Allegrini, G., Roncella, M., Caligo, M.A., Falcone, A.

Get full text

Association of SULT1A1 Arg[sup.213]His polymorphism with male breast cancer risk: results from a multicenter study in Italy by Ottini, L, Rizzolo, P, Zanna, I, Silvestri, V, Saieva, C, Falchetti, M, Masala, G, Navazio, A.S, Capalbo, C, Bianchi, S, Manoukian, S, Barile, M, Peterlongo, P, Caligo, M.A, Varesco, L, Tommasi, S, Russo, A, Giannini, G, Cortesi, L, Cini, G, Montagna, M, Radice, P, Palli, D

“…Male breast cancer (MBC) is rare and poorly understood. Like female breast cancer (FBC), MBCs are highly sensitive to hormonal changes, and hyperestrogenism,…”
Get full text

Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling by Pensabene, M., Spagnoletti, I., Capuano, I., Condello, C., Pepe, S., Contegiacomo, A., Lombardi, G., Bevilacqua, G., Caligo, M.A.

“…Although most BRCA sequence variants are clearly deleterious and unequivocally pathogenetic, several are still classified as variants of unknown significance…”
Get full text

Reply to BRCA2 splice site mutations in an Italian breast/ovarian cancer family by Pensabene, M., Spagnoletti, I., Capuano, I., Condello, C., Pepe, S., Contegiacomo, A., Lombardi, G., Bevilacqua, G., Caligo, M.A.

Get full text

Genetic alterations in hereditary breast cancer by Cipollini, G., Tommasi, S., Paradiso, A., Aretini, P., Bonatti, F., Brunetti, I., Bruno, M., Lombardi, G., Schittulli, F., Sensi, E., Tancredi, M., Bevilacqua, G., Caligo, M.A.

“…Genetic linkage studies have led to the identification of highly penetrant genes as the possible cause of inherited cancer risk in many cancer-prone families…”
Get full text

Origin of araC-induced endoreduplicated cells by Caligo, M A, Rainaldi, G

“…To investigate the origin of endoreduplicated cells induced by DNA-synthesis inhibitors, V79 Chinese hamster cells were treated with…”
Get more information

SPORADIC PANCREATIC DUCTAL CARCINOMA IN PATIENTS AGED LESS THAN 40 YEARS by Chiaro, M. Del, Menicagli, M., Campani, D., Funel, N., Pollina, L.E., Decarli, N., Collecchi, P., Bertacca, G, Michelucci, A., Cavazzana, A.O., Di Cristofano, C., Caligo, M.A., Cipollini, G., Boggi, U., Mosca, F., Bevilacqua, G.

Get full text

449 BRCA1 gene mutation carrier analysis in familial breast cancer patients by Caligo, M.A., Ghimenti, C., Ricci, S., Antonuzzo, A., Marchetti, V., Allegrini, G., Cipollini, G., Maresi, M.P., Olsen, R., McClure, M., Frye, C., Shattuck-Eidens, D., Neuhausen, S., Skolnick, M., Conte, P.F., Bevilacqua, G.

“…BRCA1, the predisposing gene for familial breast and ovarian cancer localized on chromosome 17q21.3 has been recently cloned. The gene comprises 22 coding…”
Get full text

Stimulation of carrot somatic embryogenesis by proline and serine by Ronchi, V.N, Caligo, M.A, Nozzolini, M, Luccarini, G

“…Serine and proline, when added in a wide range of concentrations to Daucus carota cultures during pre-growth in the presence of 2,4-D(2,4-dichlorophenoxyacetic…”
Get full text

BRCA 1 germline mutational spectrum in 21 Italian families by Caligo, M.A., Ghimenti, C., Cipollini, G., Ricci, S., Brunetti, I., Marchetti, V., Shattuck-Eidens, D., Conte, P.F., Skolnick, M., Bevilacqua, G.

Get full text